CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy

BACKGROUND: Cancer stem cells (CSCs) are notorious for their capacity of tumor progression, metastasis or resistance to chemo-radiotherapy. However, the undisputed role of cancer stem marker, CD133, in colorectal cancers (CRCs) is not clear yet. METHODS: We assessed 271 surgically-resected stage II...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mia-Jan, Khalilullah, Jung, So Young, Kim, Ik-Yong, Oh, Sung Soo, Choi, EunHee, Chang, Sei Jin, Kang, Tae Young, Cho, Mee-Yon
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3621413/
https://ncbi.nlm.nih.gov/pubmed/23537343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-166
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados